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Fluorescence anisotropyCholesterol is a unique molecule in terms of high level of in-built stringency, fine tuned by natural evolution
for its ability to optimize physical properties of higher eukaryotic cell membranes in relation to biological
functions. We previously demonstrated the requirement of membrane cholesterol in maintaining the ligand
binding activity of the hippocampal serotonin1A receptor. In order to test the molecular stringency of the
requirement of cholesterol, we depleted cholesterol from native hippocampal membranes followed by
replenishment with desmosterol. Desmosterol is an immediate biosynthetic precursor of cholesterol in the
Bloch pathway differing only in a double bond at the 24th position in the alkyl side chain. Our results show
that replenishment with desmosterol does not restore ligand binding activity of the serotonin1A receptor
although replenishment with cholesterol led to significant recovery of ligand binding. This is in spite of
similar membrane organization (order) in these membranes, as monitored by fluorescence anisotropy
measurements. The requirement for restoration of ligand binding activity therefore appears to be more
stringent than the requirement for the recovery of overall membrane order. These novel results have
potential implications in understanding the interaction of membrane lipids with this important neuronal
receptor in diseases such as desmosterolosis.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
G-protein coupled receptors (GPCRs) are prototypical members of
the family of seven transmembrane domain proteins involved in
signal transduction across the plasmamembrane [1]. GPCRs constitute
one of the largest family of proteins in mammals and account for 1–2%
of the total proteins coded by the human genome [2]. The serotonin1A
(5-HT1A) receptor is an important GPCR and is implicated in the
generation and modulation of various cognitive, behavioral and
developmental functions [3,4]. The serotonin1A receptor agonists [5]
and antagonists [6] represent major classes of molecules with
potential therapeutic effects in anxiety- or stress-related disorders.
Interestingly, mice lacking the serotonin1A receptor exhibit enhanced
anxiety-related behavior [7] and represent an important animal
model for genetic vulnerability to conditions such as anxiety disorders
and aggression [8].
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ll rights reserved.and sorting [9]. It is often found distributed non-randomly in domains
in biological and model membranes and has a wide variety of effects
on the physical properties of membranes [10,11]. Cholesterol is the
end product of the long and multistep sterol biosynthetic pathway.
Konrad Bloch speculated that the sterol biosynthetic pathway
parallels sterol evolution (the “Bloch hypothesis”). According to the
Bloch hypothesis, cholesterol has been selected over a very long time
scale of natural evolution for its ability to optimize certain physical
properties of eukaryotic cell membranes with regard to biological
functions [12]. Defects in the cholesterol biosynthetic pathway have
been identified with several inherited metabolic disorders such as
desmosterolosis [13-17]. Desmosterolosis is an autosomal, recessive
congenital disease and is characterized by multiple anomalies. It is
caused by mutations in 3β-hydroxy-steroid-Δ24-reductase (DHCR24),
an enzyme required in the final step of the Bloch pathway of
cholesterol biosynthesis. Desmosterolosis is clinically diagnosed with
elevated levels of desmosterol and reduced levels of cholesterol in
plasma, cells and tissues. The disease is characterized by distinct facial
anomalies, underdeveloped genital organs and abnormalities in brain
development and function, leading to serious developmental and
neurological dysfunctions. Desmosterol, an immediate biosynthetic
precursor of cholesterol in the Bloch pathway of cholesterol
biosynthesis, differs with cholesterol only in a double bond at the
24th position in the flexible alkyl side chain (see Fig.1). Desmosterol is
converted to cholesterol in the final step of the Bloch pathway by the
enzyme DHCR24. Importantly, it has been recently demonstrated that
Fig. 1. Chemical structures of desmosterol and cholesterol. Desmosterol is the immediate precursor of cholesterol in the Bloch pathway, one of the two routes of cholesterol
biosynthesis in humans. It differs with cholesterol only in a double bond at the 24th position in the flexible alkyl side chain (highlighted in its chemical structure). Elevated levels of
desmosterol have been characterized as a diagnostic parameter of desmosterolosis. See text for more details.
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with differentiation and maturation defects in the epidermis.
Dhcr24–/– mice were reported to be dead within a few hours after
birth [18].
We have previously shown the requirement of membrane
cholesterol inmaintaining ligand binding function of the hippocampal
serotonin1A receptor [19,20]. In order to explore the stringency of
cholesterol requirement, we have monitored whether desmosterol
can support the ligand binding function of the serotonin1A receptor.
Alteration in the cholesterol content of neuronal membranes could
lead to change in membrane dynamics and protein/receptor function
which represent crucial determinant in the analysis of neurogenesis
and several neuropathologies.
2. Materials and methods
2.1. Materials
BCA, desmosterol, cholesterol, MβCD, DMPC, DPH, EDTA, EGTA,
MgCl2, MnCl2, iodoacetamide, PMSF, serotonin, sucrose, polyethyle-
nimine, sodium azide, and Tris were obtained from Sigma Chemical
Co. (St. Louis, MO). BCA reagent for protein estimationwas from Pierce
(Rockford, IL). [3H]8-OH-DPAT (sp. activity 106 Ci/mmol) was
purchased from DuPont New England Nuclear (Boston, MA). GF/B
glass microfiber filters were from Whatman International (Kent, UK).
All solvents used were of analytical grade. Precoated silica gel 60 thin
layer chromatography plates were fromMerck (Darmstadt, Germany).
All other chemicals used were of the highest purity available. Water
was purified through a Millipore (Bedford, MA) Milli-Q system and
used throughout. Fresh bovine brains were obtained from a local
slaughterhouse within 10 min of death and the hippocampal region
was carefully dissected out. The hippocampi were immediately flash
frozen in liquid nitrogen and stored at –70 °C until further use.
2.2. Methods
2.2.1. Preparation of native hippocampal membranes
Native hippocampal membranes were prepared as described
previously [21]. Bovine hippocampal tissue (∼50 g) was homogenized
as 10% (w/v) in a polytron homogenizer in buffer A (2.5mMTris, 0.32M
sucrose, 5mMEDTA, 5mM EGTA, 0.02% sodium azide, 0.24 mMPMSF,
10 mM iodoacetamide, pH 7.4). The homogenate was centrifuged at
900×g for 10 min at 4 °C. The resultant supernatant was filtered
through four layers of cheesecloth and centrifuged at 50,000×g for
20min at 4 °C. The pellet obtained was suspended in 10 vol. of buffer B
(50 mM Tris, 1 mM EDTA, 0.24 mM PMSF, 10 mM iodoacetamide, pH
7.4) using a hand-held Dounce homogenizer and centrifuged at
50,000×g for 20 min at 4 °C. This procedure was repeated until the
supernatant was clear. The final pellet (native membranes) was
suspended in a minimum volume of buffer C (50 mM Tris, pH 7.4),
homogenized using a hand-held Dounce homogenizer, flash frozen inliquid nitrogen and stored at –70 °C. Protein concentration was assayed
using the BCA reagent [22].
2.2.2. Radioligand binding assays
Receptor binding assays were carried out as described earlier [19]
with some modifications. Tubes in duplicate with 0.5 mg protein in a
total volume of 1 ml of buffer D (50 mM Tris, 1 mM EDTA, 10 mM
MgCl2, 5 mM MnCl2, pH 7.4) were incubated with the radiolabeled
agonist [3H]8-OH-DPAT (final concentration in assay tube being
0.29 nM) for 1 h at 25 °C. Nonspecific binding was determined by
performing the assay in the presence of 10 μM serotonin. The binding
reaction was terminated by rapid filtration under vacuum in a Milli-
pore multiport filtration apparatus through Whatman GF/B 2.5 cm
diameter glass microfiber filters (10 µm pore size), which were
presoaked in 0.15% polyethylenimine for 1 h [23]. Filters were then
washed three times with 3 ml of cold water (4 °C), dried and the
retained radioactivity was measured in a Packard Tri-Carb 1500 liquid
scintillation counter using 5 ml of scintillation fluid.
2.2.3. Cholesterol depletion of native membranes
Native hippocampal membranes were depleted of cholesterol
using MβCD as described previously [19]. Briefly, membranes
resuspended at a protein concentration of 2 mg/ml were treated
with 40 mM MβCD in buffer C at 25 °C with constant shaking for 1 h.
Membranes were then spun down at 50,000×g for 10 min, washed
once with buffer C and resuspended in the same buffer.
2.2.4. Desmosterol and cholesterol replenishment of cholesterol-depleted
membranes
Cholesterol-depleted hippocampal membranes were replenished
with desmosterol or cholesterol using either desmosterol–MβCD or
cholesterol–MβCD complex which is soluble in water. The sterol–
MβCD complex was prepared as described previously [24]. The
complex was prepared by dissolving the required amounts of
desmosterol or cholesterol and MβCD in a ratio of 1:10 (mol/mol)
in buffer C under constant shaking at 25 °C. Stock solutions (typically
2 mM desmosterol (or cholesterol):20 mM MβCD) of this complex
were freshly prepared before each experiment. Desmosterol and
cholesterol replenishments were carried out at a protein concentration
of 2 mg/ml by incubating the cholesterol-depleted membranes with
1 mM desmosterol (or cholesterol):10 mM MβCD complex for 1 h in
buffer C at 25 °C under constant shaking. Membranes were then
spun down at 50,000×g for 10 min at 4 °C, washed with buffer C and
resuspended in the same buffer.
2.2.5. Estimation of desmosterol and cholesterol by thin layer
chromatography
Total lipids were extracted from cholesterol-depleted and sterol-
replenished membranes according to Bligh and Dyer [25]. The lipid
extracts were dried under a stream of nitrogen at 45 °C. The dried
extracts were then dissolved in a mixture of chloroform/methanol
(1:1, v/v). Sterol contents of membranes under various treatment
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impregnated with a 3% (w/v) silver nitrate in methanol, allowed to
dry briefly and activated at 120 °C for 15 min. Sterols were resolved
using chloroform/diethyl ether (95:5, v/v) as the solvent system. In
order to achieve maximum separation, TLC was run three times in
the same solvent and the plate was dried after each run. The
separated lipids were visualized by charring with a solution
containing cupric sulfate (10%, w/v) and phosphoric acid (8%, v/v)
at 150 °C. Desmosterol and cholesterol bands were identified with
the help of standards (Fig. 2A). TLC plates were scanned and sterol
band intensities were analyzed as described earlier [24].Fig. 2. Estimation of sterol content of native and cholesterol-depleted hippocampal
membranes, and cholesterol-depleted membranes replenished with cholesterol or
desmosterol. Total lipids were extracted from membranes and sterols were separated
using TLC as shown in (A). The chromatogram shows sterols from native membranes
(lane 3), membranes treated with MβCD (lane 4), and membranes treated with MβCD
followed by replenishment with either cholesterol (lane 5) or desmosterol (lane 6). The
arrows represent positions of cholesterol and desmosterol on the thin layer
chromatogram identified using standards in lanes 1 and 2, respectively. Cholesterol
(open bars), desmosterol (gray bars) and total sterol (black bars) were quantitated by
densiometric analysis of the chromatogram and are shown in (B). Values are expressed
as percentages of the cholesterol content of native membranes without any treatment
and total sterol content of membranes was obtained by the addition of cholesterol and
desmosterol contents. Data represent means±S.E. of three independent experiments.
See Section 2 for more details.2.2.6. Estimation of inorganic phosphate
The concentration of lipid phosphate was determined subsequent
to total digestion by perchloric acid [26] using Na2HPO4 as standard.
DMPC was used as an internal standard to assess lipid digestion.
Samples without perchloric acid digestion produced negligible
readings.
2.2.7. Fluorescence anisotropy measurements
Fluorescence anisotropy experiments were carried out using the
fluorescent probe DPH as described previously [27]. Steady-state
fluorescence was measured in a Hitachi F-4010 spectrofluorometer
using 1 cm path length quartz cuvettes at room temperature (∼23 °C).
Excitation and emission wavelengths were set at 358 and 430 nm.
Excitation and emission slits with nominal bandpasses of 1.5 and
20 nm were used. The optical density of the samples measured at
358 nm was 0.15±0.01. The anisotropy values remained identical
even after dilution of membrane samples, indicating the absence of
any scattering artifact [28]. Fluorescence anisotropy measurements
were performed using a Hitachi polarization accessory. Anisotropy
(r) values were calculated from the following equation [29]:
r¼ IVV−GIVH
IVV þ 2GIVH
where IVV and IVH are the measured fluorescence intensities (after
appropriate background subtraction) with the excitation polarizer
vertically oriented and the emission polarizer vertically and horizon-
tally oriented, respectively. G is the grating correction factor and is the
ratio of the efficiencies of the detection system for vertically and
horizontally polarized light and is equal to IHV/IHH. All experiments
were done with multiple sets of samples and average values of
fluorescence anisotropy are shown in Fig. 4.
2.2.8. Statistical analysis
Significance levels were estimated using Student's two-tailed
unpaired t-test using Graphpad Prism software version 4.0 (San
Diego, CA).
3. Results and discussion
The cholesterol content in hippocampal membranes exhibits
∼70% reduction upon treatment with MβCD (see Fig. 2B). This is
accompanied by a corresponding reduction (∼51%) in specific [3H]8-
OH-DPAT binding (see Fig. 3). Replenishment with cholesterol
resulted in recovery of specific [3H]8-OH-DPAT binding to ∼70% of
native membranes when the sterol (cholesterol) content was ∼87%
of control membranes (Fig. 2B). In order to examine whether
replenishment with desmosterol could restore specific ligand
binding, cholesterol-depleted membranes were replenished with
desmosterol. Interestingly, Fig. 3 shows that specific [3H]8-OH-DPAT
binding could not be restored significantly when replenishment was
carried out with desmosterol. This is in spite of the fact that the
extent of replenishment of desmosterol was comparable such that
the total sterol (cholesterol+desmosterol) was ∼85% (Fig. 2B). We
therefore conclude that desmosterol is not capable of restoring
specific ligand binding activity of the hippocampal serotonin1A
receptor. That is, the total sterol content is similar in cholesterol- and
desmosterol-replenished membranes (Fig. 2B). Importantly, the
phospholipid content remains unaltered under these conditions
(data not shown).
The above difference between cholesterol and desmosterol, in
terms of their ability to restore specific ligand binding, could be due to
alteration in overall membrane organization (order). In order to
monitor the overall membrane order, fluorescence anisotropy mea-
surements were carried out with the membrane probe, diphenyl-
hexatriene (DPH). DPH is a rod-like molecule and partitions into the
Fig. 4. Effect of replenishment of cholesterol and desmosterol into cholesterol-depleted
membranes on fluorescence anisotropy of the membrane probe DPH. Cholesterol
depletion was achieved using MβCD. Fluorescence anisotropy experiments were
performed with membranes containing 50 nmol phospholipid at a probe to
phospholipid ratio of 1:100 (mol/mol) at room temperature (∼23 °C). The values
represent means±S.E. of duplicate points from three independent experiments. See
Section 2 for more details.
Fig. 3. Effect of replenishment of cholesterol and desmosterol into cholesterol-depleted
membranes on specific binding of [3H]8-OH-DPAT to the hippocampal serotonin1A
receptor. Native membranes were treated with MβCD and were replenished with either
cholesterol or desmosterol. Values are expressed as percentages of specific binding
obtained in native membranes. Data shown are means±S.E. of five independent
experiments [⁎corresponds to significant (p=0.001) and #represents not significant
(p=0.127) difference in specific [3H]8-OH-DPAT binding of cholesterol- and desmosterol
replenished membranes, respectively, in comparison to MβCD treated membranes
(cholesterol-depleted membranes)]. See Section 2 for more details.
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rotational diffusion of membrane embedded probes such as DPH [29],
which is sensitive to the packing of lipid acyl chains. Fig. 4 shows that
the fluorescence anisotropy of DPH exhibits a significant reduction
upon cholesterol depletion from native membranes. Interestingly,
fluorescence anisotropy is restored to the same extent upon
cholesterol and desmosterol replenishments. This points out that
the differential effect of sterols on specific ligand binding is not due to
change in membrane order.
Previous work from our laboratory demonstrated the necessity of
membrane cholesterol in maintaining the ligand binding function of
the hippocampal serotonin1A receptor [19,30]. Interestingly, the
function of serotonin7a receptors has subsequently been shown to
exhibit cholesterol dependence [31] (for a comprehensive list of
GPCRs whose function depend on membrane cholesterol, see [32]). In
this paper, we have replaced cholesterol with desmosterol to test the
stringency of the requirement of membrane cholesterol in maintaining
the function of the hippocampal serotonin1A receptor. Desmosterol
differs with cholesterol only in a double bond at the 24th position. Our
results demonstrate that desmosterol is not capable of supporting the
ligand binding function of the serotonin1A receptor. This result is
interesting in the light of the fact that replenishment with cholesterol
and desmosterol resulted in comparable overall membrane order. This
reinforces the fact that the requirement for ligand binding is more
stringent than that of overall membrane organization. It should be
noted here that desmosterol can replace cholesterol in sustaining cell
proliferation and regulating the pathway of cholesterol homeostasis
[33]. Moreover, earlier biophysical measurements by us [34] and others
[35] have shown that the effects of cholesterol and desmosterol on
membrane organization and dynamics are similar. Interestingly, it has
been reported that Dhcr24 gene knockout (Dhcr24–/–) mice (i.e., mice
with predominantly desmosterol and almost no cholesterol) develop a
number of abnormalities from sterility [36] to lethal dermopathy [18].
Our present results are reminiscent of our earlier work inwhichwe
showed that 7-dehydrocholesterol (7-DHC, an immediate biosyn-
thetic precursor of cholesterol in the Kandutsch–Russell pathway,
differing with cholesterol only in a double bond at the 7th position)
does not support the function of the serotonin1A receptor [24,37]. This
is in support of the proposition that cholesterol represents a moleculewith high level of in-built stringency, fine tuned bymillions of years of
natural evolution for its ability to optimize physical properties of
eukaryotic cell membranes in relation to biological functions [12,34].
The molecular mechanism underlying the effect of cholesterol on
the structure and function of integral membrane proteins is not
always clear [20,38]. It has been proposed that such effects could occur
either due to a specific molecular interactionwith membrane proteins
leading to a conformational change in the receptor [39,40], or due to
alterations in the membrane physical properties induced by the
presence of cholesterol [41,42], or due to a combination of both
factors. We previously reported that oxidation of membrane choles-
terol results in inhibition of the ligand binding function of the
hippocampal serotonin1A receptor without any alteration in overall
membrane order [43]. As mentioned earlier, we recently showed that
7-DHC, an immediate biosynthetic precursor of cholesterol with an
extra double bond, does not support the function of the serotonin1A
receptor, even when there is no change in overall membrane order
[24,37]. Taken together, these results show that the requirement of
membrane cholesterol in maintaining the ligand binding function of
serotonin1A receptors could be attributed to specific interaction,
although global bilayer effects may not be completely ruled out [44].
We have recently proposed that membrane cholesterol could
occupy “nonannular” binding sites in GPCRs [32,45]. Nonannular sites
are characterized by lack of accessibility to the annular lipids, i.e., lipid
in these sites cannot be displaced by competition with annular lipids
[46]. The binding to the nonannular sites is believed to be more
specific compared to binding to annular sites [47]. The possible
locations for the nonannular sites have been postulated to be either
inter- or intramolecular (interhelical) protein interfaces, characterized
as deep clefts (or cavities) on the protein surface [46,48]. It is therefore
possible that the inability of desmosterol to support the ligand binding
activity of the serotonin1A receptor could be due to its relative inability
(in comparison to cholesterol) to be accommodated at the nonannular
sites. It is not possible at this point in time to predict the relative ease
of accommodating closely related sterols to the nonannular binding
sites of membrane receptors. A combination of X-ray crystallographic
structures and molecular modeling could provide useful insight in
addressing the issue of lipid shape and binding to nonannular sites. In
summary, our results have potential implications in understanding
the interaction of membrane cholesterol with the serotonin1A
2173P. Singh et al. / Biochimica et Biophysica Acta 1788 (2009) 2169–2173receptor, in general and under desmosterolosis-like condition in
particular. Our future work will focus on generating desmosterolosis-
like condition in a cellular model andmonitoring serotonin1A receptor
signaling under such condition.
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